Search

Your search keyword '"Wisit Prasithsirikul"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Wisit Prasithsirikul" Remove constraint Author: "Wisit Prasithsirikul"
77 results on '"Wisit Prasithsirikul"'

Search Results

1. Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection

2. Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine

3. Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia

4. Comparison of the Immune Response After an Extended Primary Series of COVID-19 Vaccination in Kidney Transplant Recipients Receiving Standard Versus Mycophenolic Acid–sparing Immunosuppressive Regimen

5. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection

6. Assessment of anxiety and depression among hospitalized COVID-19 patients in Thailand during the first wave of the pandemic: a cross-sectional study

7. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand

8. Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study

9. ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis

10. Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand.

11. Potential dual dengue and SARS-CoV-2 infection in Thailand: A case study

12. Immunogenicity of ChAdOx1 nCoV-19 Booster Vaccination Following Two CoronaVac Shots in Healthcare Workers

13. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection.

14. Simultaneously complete but not partial taste and smell losses were associated with SARS-CoV-2 infection

15. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand

16. Adjunctive favipiravir for severe COVID-19: a retrospective observational study of the first 41 patients in Thailand

17. Prevalence and genotype distribution of hepatitis C virus within hemodialysis units in Thailand: role of HCV core antigen in the assessment of viremia

18. Assessment of anxiety and depression among hospitalized COVID-19 patients in Thailand during the first wave of the pandemic: a cross-sectional study

19. Multiple clades of SARS-CoV-2 were introduced to Thailand during the first quarter of 2020

20. Clinical Characteristics and Treatment Outcomes of Mild COVID-19 Patients in Field Hospital: A Cross-Sectional Study.

21. Journey of a Thai Taxi Driver and Novel Coronavirus

22. Chronic kidney disease incidence and survival of Thai HIV-infected patients

23. Clinical course and potential predictive factors for pneumonia of adult patients with Coronavirus Disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand

24. Effect of nutritional counseling on low-density lipoprotein cholesterol among Thai HIV-infected adults receiving antiretroviral therapy

25. Risk of First-line Antiretroviral Therapy Failure in HIV-infected Thai Children and Adolescents

26. Prevalence of Metabolic Syndrome Among Antiretroviral-Naive and Antiretroviral-Experienced HIV-1 Infected Thai Adults

27. Long-term outcomes of HIV-infected children in Thailand: the Thailand Pediatric HIV Observational Database

28. Clinical Characteristics of Patients Hospitalized with Coronavirus Disease, Thailand.

29. Depression and anxiety were low amongst virally suppressed, long-term treated HIV-infected individuals enrolled in a public sector antiretroviral program in Thailand

30. Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial

31. Effectiveness of Boosted Protease Inhibitor-Based Regimens in HIV Type 1-Infected Patients Who Experienced Virological Failure with NNRTI-Based Antiretroviral Therapy in a Resource-Limited Setting

32. The Impact of Combination Antiretroviral Therapy and its Interruption on Anxiety, Stress, Depression and Quality of Life in Thai Patients

33. Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study

34. Nevirapine Levels after Discontinuation of Rifampicin Therapy and 60‐Week Efficacy of Nevirapine‐Based Antiretroviral Therapy in HIV‐Infected Patients with Tuberculosis

35. A Single-Nucleotide Polymorphism in ABCC4 Is Associated with Tenofovir-Related Beta2-Microglobulinuria in Thai Patients with HIV-1 Infection

36. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

37. Ritonavir-boosted lopinavir as maintenance monotherapy in HIV-infected patients who achieved viral suppression during a second-line protease inhibitor-based regimen: a pilot randomized trial (BIDI-MONO)

38. A Prospective Study of Efficacy and Safety of Once-Daily Saquinavir/Ritonavir plus Two Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Thai Patients

39. Effect of nutritional counseling on LDL cholesterol among Thai HIV-infected adults

40. Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection

41. Plasma Nevirapine Levels and 24‐Week Efficacy in HIV‐Infected Patients Receiving Nevirapine‐Based Highly Active Antiretroviral Therapy with or without Rifampicin

42. Polymorphisms in Fas gene is associated with HIV-related lipoatrophy in Thai patients

43. Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy

44. Skin manifestation of Thai HIV infected patients in HAART era

45. A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study

46. Prevalence trend of renal replacement therapy in Thailand: impact of health economics policy

47. Etravirine and rilpivirine resistance in HIV-1 subtype CRF01_AE-infected adults failing non-nucleoside reverse transcriptase inhibitor-based regimens

48. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting

49. Two-year safety and tolerability study of enfuvertide use in salvage therapy of Thai HIV-1 experienced cases

50. Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure

Catalog

Books, media, physical & digital resources